Skip to main content

Site notifications

Amoxicillin capsules, USP 250mg (Sandoz)

Section 19A approved medicine
Amoxicillin capsules, USP 250mg (Sandoz)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
1300 788 261
Approved until
Medicines in short supply/unavailable
ALPHAMOX 250 amoxicillin 250mg (as trihydrate) capsule blister pack - ARTG 17678

Treatment of the following infections due to susceptible strains of sensitive organisms:

Note: Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. Amoxicillin alone or in combination with another antibiotic, may be used in an emergency where the causative has not been identified.

  • Respiratory tract infections (acute and chronic): H. influenzae; Streptococcus; S.pneumoniae; Staphylococcus, nonpenicillinase producing; E. coli.
  • Urogenital infections (complicated and uncomplicated, acute and chronic): E.coli P.mirabilis and Strep. faecalis.
  • Gonorrhoea: N.gonorrhoea (nonpencillinase producing).
  • Skin and skin structure infections: Staphylococcus, nonpenicillinase producing; Streptococcus; E. coli.
  • Prophylaxis of endocarditis: Amoxicillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
Picture of Amoxicillin capsules, USP 250mg (Sandoz)

Help us improve the Therapeutic Goods Administration site